惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

T
Tenable Blog
K
KPMG report finds enterprise disconnect between AI and its ROI | CIO
V
Vulnerabilities – Threatpost
G
GRAHAM CLULEY
Simon Willison's Weblog
Simon Willison's Weblog
C
CXSECURITY Database RSS Feed - CXSecurity.com
P
Privacy International News Feed
H
Heimdal Security Blog
Exploit-DB.com RSS Feed
Exploit-DB.com RSS Feed
S
Secure Thoughts
MyScale Blog
MyScale Blog
C
Cyber Attacks, Cyber Crime and Cyber Security
V
Visual Studio Blog
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
L
LINUX DO - 最新话题
D
Darknet – Hacking Tools, Hacker News & Cyber Security
The Cloudflare Blog
美团技术团队
Recorded Future
Recorded Future
T
Tailwind CSS Blog
Latest news
Latest news
Security Archives - TechRepublic
Security Archives - TechRepublic
Security Latest
Security Latest
Know Your Adversary
Know Your Adversary
Cloudbric
Cloudbric
Schneier on Security
Schneier on Security
I
Intezer
L
LINUX DO - 热门话题
P
Palo Alto Networks Blog
云风的 BLOG
云风的 BLOG
cs.CL updates on arXiv.org
cs.CL updates on arXiv.org
Vercel News
Vercel News
Attack and Defense Labs
Attack and Defense Labs
人人都是产品经理
人人都是产品经理
L
LangChain Blog
爱范儿
爱范儿
博客园 - 三生石上(FineUI控件)
博客园 - 叶小钗
L
Lohrmann on Cybersecurity
S
SegmentFault 最新的问题
W
WeLiveSecurity
C
Cybersecurity and Infrastructure Security Agency CISA
S
Securelist
SecWiki News
SecWiki News
V2EX - 技术
V2EX - 技术
IT之家
IT之家
Cyberwarzone
Cyberwarzone
F
Full Disclosure
Spread Privacy
Spread Privacy
阮一峰的网络日志
阮一峰的网络日志

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t
Meggen Harris · 2026-04-24 · via Forbes - Healthcare

Peptides are increasingly used in clinical, aesthetic and longevity settings, but questions remain around regulation, safety and who is qualified to prescribe them.

getty

Peptides are having a moment.

They’re being positioned as solutions for everything from skin health and recovery to weight loss and longevity. Scroll through social media or spend time in wellness circles, and it doesn’t take long before they come up—often framed as the next frontier in personalized health.

I’ll be honest: I’m not coming at this from a place of skepticism. I’m exploring peptides myself from both a health and longevity perspective. But the deeper I’ve gone into the space, the more one question kept surfacing:

Who is actually qualified to be giving advice on them?

Because unlike more established areas of medicine, peptides sit in a gray zone—part clinical, part experimental, and increasingly, part content.

What Peptides Are—And Why They’re Suddenly Everywhere

Peptides are short chains of amino acids that act as signaling molecules in the body, influencing processes such as metabolism, inflammation and tissue repair.

getty

At a basic level, peptides are short chains of amino acids that act as signaling molecules in the body, influencing processes like hormone production, inflammation, metabolism, and tissue repair.

That functionality is what’s driving their appeal.

In clinical settings, certain peptides have been studied and prescribed for specific uses. But in recent years, interest has expanded far beyond traditional medicine into longevity clinics, aesthetic practices, telehealth platforms, and direct-to-consumer wellness brands.

The result is a rapidly growing market and a much broader range of voices talking about them.

Why The Advice Around Peptides Feels So Fragmented

Part of the confusion comes down to how—and where—peptides are being used.

Some are prescribed by licensed medical professionals through regulated channels. Others are compounded or customized through clinics operating at the edge of traditional medical frameworks. Then there’s the growing layer of advice coming from influencers, biohackers, and wellness personalities—many of whom are sharing personal experience but not operating within a clinical scope.

At the same time, regulation hasn’t fully caught up.

Different peptides fall into different categories—some are FDA-approved for specific uses, others are prescribed off-label, and some are sold as “research-use-only” compounds that are not approved for human consumption, even as peptides continue to gain traction in mainstream health and wellness conversations.

That’s where the lines begin to blur.

Who Is Actually Qualified To Prescribe Or Recommend Peptides

In most cases, peptides are prescribed by licensed medical professionals, though training and experience in their use can vary widely.

getty

This is where things become more straightforward—and where the gap between perception and reality becomes clear.

In most cases, prescribing peptides is limited to licensed medical professionals, including physicians, nurse practitioners, and physician assistants, depending on state regulations and scope of practice.

But even within medicine, this isn’t a universally understood category.

From a regulatory standpoint, the landscape is also more constrained than it often appears. Only a limited number of peptides are approved by the FDA for specific medical uses. Others may be prescribed off-label by licensed providers or compounded under certain conditions, while many of the peptides frequently discussed in wellness and anti-aging circles are classified as “research-use-only” and are not approved for human consumption.

That distinction matters particularly as peptides move further into mainstream wellness conversations, often without the same level of context.

One functional medicine doctor I spoke with noted that only a small subset of physicians in the U.S., which he estimated to be roughly 50 or so, are both experienced and comfortable prescribing peptides. It’s not widely taught in medical training, which creates a gap at the highest level of care.

That gap is part of what’s driving the current landscape.

There is real interest. There is emerging science. But there is also a lack of standardized education.

Where The Risks Of Peptides Come In

As peptides become more widely used, many are self-administered outside traditional clinical settings—raising questions around safety, sourcing and oversight.

getty

The appeal of peptides is tied to their potential—but so are the risks.

Without proper oversight, variables like dosage, quality, and sourcing can vary significantly, with research pointing to potential safety concerns depending on purity, administration, and individual response.

Some peptides are obtained through compounding pharmacies, while others are purchased through less regulated channels, increasing the potential for inconsistency or contamination.

There’s also a legal dimension that often gets overlooked.

Recommending peptides, particularly for the treatment of specific conditions, can cross into the unauthorized practice of medicine when done by unlicensed individuals. Furthermore, promoting “research-use-only” peptides for human consumption falls outside of FDA guidelines.

None of this means peptides don’t have value. But it does mean that both context and oversight matter more than the current conversation often reflects.

What To Look For Before Taking Peptides

Working with a qualified medical professional can help ensure peptides are used safely, appropriately and with proper oversight.

getty

For those considering peptides, clarity starts with who you’re getting information from.

Licensed medical professionals operate within a defined scope: they can evaluate your health history, assess risk, and monitor outcomes. That’s fundamentally different from someone sharing personal experience, particularly if they are also selling products or protocols tied to those recommendations.

That’s where the gray area becomes more complicated.

There’s nothing inherently wrong with experimentation or curiosity. But health decisions shouldn’t fall entirely under caveat emptor—especially when the lines between education, influence, and commerce are increasingly blurred.

It’s also worth stepping back and asking a more basic question: what problem are you trying to solve?

In many cases, peptides are being layered into broader conversations around health, aging, and performance—areas where foundational factors like sleep, nutrition, and movement still play a central role.

The Bottom Line

Peptides may be one of the fastest-growing areas in wellness right now, but the conversation around them hasn’t fully caught up.

As interest expands, so does the range of voices offering guidance, making it harder to distinguish between expertise, experience, and opinion.

This isn’t about being anti-peptide—or anti-innovation.

It’s about recognizing that when it comes to health, who is giving the advice matters just as much as the advice itself.